Beachbody Company, Inc. (BODI) stock intrinsic value fair value estimate & owner earnings analysis

BODi (formerly The Beachbody Company) sells home fitness content through a digital streaming subscription (workout programs, live and on-demand classes) alongside nutrition products, most notably its long-running Shakeology shake line, sold direct to consumers primarily in the United States, with smaller sales in Canada, the United Kingdom and France. The business has been shrinking for five straight years. Revenue peaked near $874 million in 2021, the year the company went public through a merger with a special-purpose acquisition company, and has fallen every year since as pandemic-era demand faded and digital subscribers and nutrition customers both declined. In 2025, revenue fell again to $252 million, down 40% from the prior year, with both the digital subscription business (down 32%) and the nutrition business (down 48%) shrinking sharply. The pace of decline moderated somewhat in the first half of 2026, down about 24% from a year earlier, but the business is still contracting. What changed in 2025 is profitability, not growth. Management ran a cost-restructuring program (referred to internally as "the Pivot") that cut stock-based compensation by two-thirds and reduced selling and marketing spending by over 10 percentage points of revenue. As a result, 2025 was the first year in several that the company generated real cash profit after accounting for the true ongoing cost of the business, including the cost of continually producing new workout content (which this analysis treats as an ongoing operating cost, not a one-time or reversible item, since stale content is what drives subscriber cancellations). That is a meaningful, already-realized change, not a hoped-for one. In the first half of 2026 the company also refinanced its previous, extremely expensive loan (which carried a 28% effective interest rate) into a new asset-based credit facility maturing in 2028, carrying a materially lower but still elevated rate (currently in the 13-15% range, falling further only if certain profitability covenants are met). Cash on hand roughly offsets this debt today, so the balance-sheet drag on a per-share basis is small, but the facility's cost is a genuine ongoing burden and its 2028 maturity is a date to watch if the business has not stabilized by then. The central question for value is whether the business's decline is decelerating toward a stable, smaller size, or continuing indefinitely. The base case assumes the deceleration seen so far continues, gradually approaching a much smaller but durable subscription and nutrition business over the next several years, informed by the discipline already shown on costs. The bull case assumes stabilization happens sooner and the cost discipline delivers real operating leverage once revenue stops shrinking, supported by the improvement already achieved. The bear case assumes the recent deceleration does not hold, revenue keeps falling at a high rate throughout the next decade, and fixed costs (including the interest cost on the credit facility) erode profitability faster than management can cut, leaving little value beyond the company's current cash. Only two quarters of deceleration data exist so far, which is a real limitation: this is not yet a proven floor, only a promising trend. That uncertainty is the main reason for the wide range between the bear and bull outcomes here, and is the assumption most likely to be wrong in either direction.